- Transenteric delivery of incretin triagonist of GLP-1, GIP, glucagon receptors elicits rapid weight loss in animal study –- Preclinical data support the potential for the RaniPill platform to enable oral delivery of
SAN DIEGO, Aug. 30, 2022 /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN), a global leader in DNA sequencing and array-based technologies, today announced the opening of its first manufacturing site in China.